abstract |
The present invention relates to a pharmaceutical composition for treating or preventing cancer, a pharmaceutical composition for enhancing immunity, a method for screening an anticancer drug, and a method for providing information necessary for cancer prognosis analysis. According to the present invention, cancer can be effectively prevented or treated by using an inhibitor of KIRREL3, CNTN4 and/or CD351, and an individual's immunity can be enhanced. In addition, the present invention can effectively select new anticancer drug candidates by measuring the activity or expression of KIRREL3, CNTN4 and/or CD351, and is very useful because it can provide information necessary for diagnosis and prediction of cancer prognosis. |